Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.

Yoji Hamada, Norio Hotta|Diabetes Care|2000

Cited by 91